Zobrazeno 1 - 10
of 35
pro vyhledávání: '"E. Coen Beuvery"'
Autor:
E. Coen Beuvery, José M. Coco Martin
Publikováno v:
Flow Cytometry Applications in Cell Culture
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a109fa0d3ba4bfeb4c741ef66f94711
https://doi.org/10.4324/9781003067467-5
https://doi.org/10.4324/9781003067467-5
Publikováno v:
Engineering in Life Sciences. 13:212-223
The process analytical technology (PAT) initiative is now 10 years old. This has resulted in the development of many tools and software packages dedicated to PAT application on pharmaceutical processes. However, most applications are restricted to sm
Autor:
Bas van de Waterbeemd, Johannes Tramper, E. Coen Beuvery, Dirk E. Martens, Mathieu Streefland, Joeri Kint, Leo A. van der Pol
Publikováno v:
Biotechnology and Bioengineering 102 (2009) 1
Biotechnology and Bioengineering, 102(1), 161-167
Biotechnology and Bioengineering, 102(1), 161-167
Modern (bio)pharmaceutical process development requires thorough investigation of all process parameters that are critical to product quality. The impact of a disturbance of such a parameter during processing needs to be known so that a rational deci
Autor:
Merja Roivainen, Leila Litmanen, Tapani Hovi, Liisa Piirainen, Juhani Eskola, E. Coen Beuvery
Publikováno v:
Vaccine. 15:237-243
A modified trivalent enhanced potency IPV (E-IPV) containing trypsin-treated PV3/Saukett as the type 3-component (TryIPV) was evaluated in preclinical and Phase I and Phase II clinical trials with the regular E-IPV as a control. In Balb/c mice, TryIP
Autor:
Gijsbert van Steenis, Ruth F. Bishop, Rudiwilai Samakoses, Helen C. Bugg, Bruce L. Davidson, Sriluck Simasathien, Punnee Pitisuttitham, Preyapan Sangaroon, E. Coen Beuvery, Timo Vesikari, S. Migasena
Publikováno v:
Vaccine. 13:168-174
Rhesus-human reassortant tetravalent (RRV-TV) oral rotavirus vaccine was given at the same time as oral poliovirus vaccine (OPV) or inactivated parenteral poliovirus vaccine (IPV) to Thai infants at 2, 4 and 6 months of age. Sera for rotavirus antibo
Autor:
Tiny A. M. van der Velden-de Groot, E. Coen Beuvery, Jan W. Oberink, Freek Brunink, José M. Coco-Martin
Publikováno v:
Hybridoma. 11:653-665
In this study several analytical techniques were applied to obtain information about the stability of expression, the yield, and the integrity of a monoclonal antibody (Mab) produced by hybridoma cell line RIV6 in a homogeneous continuous perfusion c
Publikováno v:
Analytical Biochemistry. 196:421-426
A simple and rapid method for determining the affinity constant of a monoclonal antibody-peptide complex under equilibrium conditions is presented. A peptide corresponding to sequence 178-185 of meningococcal strain MC50 class 1 outer membrane protei
Autor:
E. Coen Beuvery, Daan J.A. Crommelin, Tiny A. M. van der Velden-de Groot, Anna-Myra V. Hoven, Wim Jiskoot, Jacqueline W.T.M. Klein Gebbinck, Jos J.C.C. Van Hertrooij
Publikováno v:
Journal of Immunological Methods. 138:273-283
Three mouse monoclonal antibodies (Mab), RIV6, MN12, and WT31, were purified from cell culture supernatants containing foetal bovine serum (FBS) by two-step purification protocols, involving protein A affinity and ion exchange chromatography. Provide
Publikováno v:
Analytica Chimica Acta. 249:257-262
Several analytical techniques were applied to obtain information about the stability of expression, yield and integrity of monoclonal antibodies (Mabs) produced by hybridoma cells in homogeneous continuous perfusion culture systems. An isotype-specif
Autor:
Gino Baart, Marieke Willemsen, E. Coen Beuvery, Elnaz Khatami, Johannes Tramper, Dirk E. Martens, Alex de Haan, Bert Zomer
Publikováno v:
Biotechnology and Bioengineering, 101(5), 1022-1035
Biotechnology and Bioengineering 101 (2008) 5
Biotechnology and Bioengineering 101 (2008) 5
Neisseria meningitidis is a human pathogen that can infect diverse sites within the human host. The major diseases caused by N. meningitidis are responsible for death and disability, especially in young infants. At the Netherlands Vaccine Institute (